Filed: 2/6/2026ACC: 0001104659-26-011601
📋 What this filing means
REGENERON PHARMACEUTICALS, INC. filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $33.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$33.80M
Total AUM (reported)
3.76M
Total Shares
Allocation by class
COMMON STOCK$33.80M100.0%
Portfolio Concentration
Top 3$33.80M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 3.76M
Sole
Full voting authority
3.76M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Intellia Therapeutics, Inc.
SOLEShares3.70M
TypeSH
Market value$33.29M
98.49%
Sole
3.70M
Shared
0.00
None
0.00
Adicet Bio, Inc.
SOLEShares60.51K
TypeSH
Market value$509.5K
1.51%
Sole
60.51K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc.SOLE | Common Stock | 3.70M | SH | $33.29M 98.49% | 3.70M | 0.00 | 0.00 |
Adicet Bio, Inc.SOLE | Common Stock | 60.51K | SH | $509.5K 1.51% | 60.51K | 0.00 | 0.00 |